Highbridge Capital Management’s PRA Health Sciences, Inc. PRAH Stock Holding History

Highbridge Capital Management’s Portfolio PRAH Stock Details PRAH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q2	–	Sell	-67,910	Closed	-$4.43M	–	1736
2017 Q1	$4.43M	Buy	+67,910	New	+$4M	0.06%	319
2016 Q3	–	Sell	-256,212	Closed	-$10.7M	–	1781
2016 Q2	$10.7M	Buy	256,212 +110,640	+76%	+$5.1M	0.17%	153
2016 Q1	$6.22M	Buy	+145,572	New	+$6.15M	0.1%	230
2015 Q3	–	Sell	-83,440	Closed	-$3.03M	–	1910
2015 Q2	$3.03M	Buy	+83,440	New	+$2.64M	0.04%	412

Other funds holding PRAH

KKRC

Kohlberg Kravis Roberts & Co New York $5.35B AUM 63.01% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return

EAM

Eagle Asset Management St Petersburg, Florida $19.6B AUM 41.58% 1-Year Est. Return

CWAM

Columbia Wanger Asset Management Chicago, Illinois $6.69B AUM 31.14% 1-Year Est. Return

DZ Bank Frankfurt Am Main, Germany $113B AUM 36.92% 1-Year Est. Return

BAMCO Inc New York $33.1B AUM 11.16% 1-Year Est. Return

Russell Investments Group London, United Kingdom $93.1B AUM 28.26% 1-Year Est. Return

Highbridge Capital Management's PRAH Position: Q2 2017 in Review

Highbridge Capital Management sold out of PRA Health Sciences, Inc. (PRAH) in Q2 2017, closing a stake of 67,910 shares — an estimated $4.43M sold.

Highbridge Capital Management first reported a position in PRAH in Q2 2015 and held it in 4 quarters. The position peaked at $10.7M in Q2 2016. 235 funds tracked by Wall St. Rank hold PRAH as of Q2 2017.

Highbridge Capital Management reported no remaining PRA Health Sciences, Inc. position as of Q2 2017 after selling out during the quarter.
Highbridge Capital Management sold 67,910 PRA Health Sciences, Inc. shares in Q2 2017, an estimated $4.43M.
Highbridge Capital Management first reported a position in PRA Health Sciences, Inc. in Q2 2015 and held it in 4 quarters.
Highbridge Capital Management's PRA Health Sciences, Inc. position peaked at $10.7M in Q2 2016.
235 funds tracked by Wall St. Rank held PRA Health Sciences, Inc. as of Q2 2017.

Based on Highbridge Capital Management's 13F filing for Q2 2017, filed 14 Aug 2017.